Literature DB >> 17220825

Steroid-induced ptosis: case studies and histopathologic analysis.

A Song1, K D Carter, J A Nerad, C Boldt, J Folk.   

Abstract

PURPOSE: The purpose of this study was to review patients who developed ptosis after subtenon's steroid injection and to study the mechanism of steroid-induced ptosis in an animal model.
METHODS: Part 1. Twenty-two patients with uveitis who had received posterior subtenon's triamcinolone acetonide injections were retrospectively reviewed. Demographics, type of uveitis, type and number of surgeries, pre and postoperative marginal reflex distance (MRD1), and clinical outcomes were evaluated. Part 2. Study of rabbit levator muscle and aponeurosis histopathology after subtenon's triamcinolone injection was performed.
RESULTS: Part 1. The average age was 44.6 years (range: 14-85 years) with a mean follow-up of 14 months. The most common causes of uveitis included uveitis after cataract extraction (five), pars planitis (three), multifocal choroiditis (three), and juvenile rheumatoid arthritis (three). The average time to documented onset of ptosis was 13.9 months (range: 0-49 months). In patients who received only one steroid injection, the average time to ptosis recorded was 2.7 months (range: 0-6 months). Seventeen patients underwent ptosis repair. Part 2. No ptosis was noted in the experimental and control groups. Histopathologic analysis of levator tissues revealed no significant difference in atrophy or degree of inflammation between experimental and control groups.
CONCLUSIONS: Ptosis following subtenon's steroid injection ranged from mild to moderate and occurred a few months after steroid injection. Prior studies of muscles and periocular tissues exposed to corticosteroids demonstrated degenerative muscle changes; our studies revealed no histopathologic changes in the levator muscle or aponeurosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220825     DOI: 10.1038/sj.eye.6702667

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  7 in total

1.  Corticosteroid eyedrops induced blepharoptosis and atrophy of levator muscle.

Authors:  Xiao Zhang; Mei-Fen Zhang; Da-Chun Zhao; Xiao-Wei Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-15       Impact factor: 3.117

2.  Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy.

Authors:  Dong-Dong Xu; Yu Chen; Hai-Yan Xu; Hui Li; Zhu-Hua Zhang; Yu-Hua Liu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

3.  Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.

Authors:  Sung Jun Lee; Tyler Hyung Taek Rim; Sun Young Jang; Chan Yun Kim; Dong Yeob Shin; Eun Jig Lee; Sang Yeul Lee; Jin Sook Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-12       Impact factor: 3.117

4.  Relative incidence of blepharoptosis subtypes in an oculoplastics practice at a tertiary care center.

Authors:  Janet M Lim; Joshua H Hou; Ramesh M Singa; Vinay K Aakalu; Pete Setabutr
Journal:  Orbit       Date:  2013-05-10

Review 5.  Management of eyelid retraction related to thyroid eye disease.

Authors:  Tammy H Osaki; Lucas G Monteiro; Midori H Osaki
Journal:  Taiwan J Ophthalmol       Date:  2022-02-14

6.  Ptosis induced by topical steroid eye drops: Two cases reports.

Authors:  Yanan Zhu; Chaohui Sun; Xin Zhang; Xingchao Shentu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  Bilateral inferior oblique muscle paresis after posterior subtenon injection of triamcinolone acetonide.

Authors:  Tso-Ting Lai; Tzu-Hsun Tsai; Chung-May Yang
Journal:  Taiwan J Ophthalmol       Date:  2014-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.